Figure 2From: Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: reanalysis of the findings of a single-center prospective study Comparison of local-regional progression-free survival between patients who underwent four to five cycles of chemotherapy concurrently with radiotherapy at doses of ≥63 Gy and patients who received other treatment regimens. Back to article page